Search Clinical Trials
589,776 trials
ID
Status
Phase
Title
Sponsor
NCT07652788
Efficacy of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)Centre Hospitalier St AnneNot Yet RecruitingNot Applicable
NCT07652788Not Yet Recruiting
Not Applicable
Efficacy of Transcranial Direct Current Stimulation (tDCS) in the Treatment of A...Centre Hospitalier St Ann...
NCT07653074
Functional Vision and Quality of Life in a Modern Society - With Emphasis on Myopia and Cerebral Visual Impairment Among YouthGöteborg UniversityRecruiting
NCT07653074Recruiting
—
Functional Vision and Quality of Life in a Modern Society - With Emphasis on Myo...Göteborg University
NCT07653867
Patient Controlled Propofol Sedation Versus Nurse-assisted Propofol Sedation in Diagnostic Colonoscopies With a Focus on Patient SatisfactionKarolinska InstitutetNot Yet RecruitingPhase 4
NCT07653867Not Yet Recruiting
Phase 4
Patient Controlled Propofol Sedation Versus Nurse-assisted Propofol Sedation in...Karolinska Institutet
NCT07654205
Smartphone-based Intervention for Young Adults With ADHDNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingNot Applicable
NCT07654205Recruiting
Not Applicable
Smartphone-based Intervention for Young Adults With ADHDNational Institute on Alc...
NCT07654192
The Effect of ShotBlocker and Finger Puppet on Pain and Fear During Blood Drawing in ChildrenAbant Izzet Baysal UniversityEnrolling By InvitationNot Applicable
NCT07654192Enrolling By Invitation
Not Applicable
The Effect of ShotBlocker and Finger Puppet on Pain and Fear During Blood Drawin...Abant Izzet Baysal Univer...
NCT07653477
Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)The United Bio-Technology (Hengqin) Co., Ltd.Not Yet RecruitingPhase 3
NCT07653477Not Yet Recruiting
Phase 3
Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadeq...The United Bio-Technology...
NCT07652645
Hybrid Dialectical Behavior Therapy for Veterans to Further Reduce Emotion Regulation Problems and Trauma SymptomsArkinRecruitingNot Applicable
NCT07652645Recruiting
Not Applicable
Hybrid Dialectical Behavior Therapy for Veterans to Further Reduce Emotion Regul...Arkin
NCT07653932
Perioperative Quantitative Sensory Testing and Incision Pain Mapping in Thoracic SurgeryTongji HospitalNot Yet Recruiting
NCT07653932Not Yet Recruiting
—
Perioperative Quantitative Sensory Testing and Incision Pain Mapping in Thoracic...Tongji Hospital
NCT07655024
TAIC FOLFOX for Locally Advanced G/GEJAGuang'anmen Hospital of China Academy of Chinese Medical SciencesRecruitingPhase 2
NCT07654777
The Efficacy of Vitamin D Supplementation to Sustain Performance OutcomesWalter Reed Army Institute of Research (WRAIR)RecruitingNot Applicable
NCT07654777Recruiting
Not Applicable
The Efficacy of Vitamin D Supplementation to Sustain Performance OutcomesWalter Reed Army Institut...
NCT07653581
rhTPO + CsA vs CsA in the Treatment of LR-MDS With ThrombocytopeniaPeking Union Medical College HospitalNot Yet RecruitingPhase 3
NCT07653581Not Yet Recruiting
Phase 3
rhTPO + CsA vs CsA in the Treatment of LR-MDS With ThrombocytopeniaPeking Union Medical Coll...
NCT07652385
Transnasal Microstream EtCO2 Reduces Hypoxemia During Emergence in Aged Post-Abdomen SurgeryJianbo WuNot Yet RecruitingNot Applicable
NCT07652385Not Yet Recruiting
Not Applicable
Transnasal Microstream EtCO2 Reduces Hypoxemia During Emergence in Aged Post-Abd...Jianbo Wu
NCT07655115
Single Dose Double-blind, Placebo-controlled Cross-over (SDDBPCCO) Shiftability Study, Will be Followed by a 10-week Open-label Study With Arbaclofen (4 Weeks of Titration and Then 6 Weeks of Active/Stable Treatment). The Effects of Arbaclofen on Target EEG and ERG Metrics Will be Associated With thFundación para la Investigación Biomédica del Hospital Gregorio MaranonRecruitingPhase 3
NCT07655115Recruiting
Phase 3
Single Dose Double-blind, Placebo-controlled Cross-over (SDDBPCCO) Shiftability...Fundación para la Investi...
NCT07653685
A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the Treatment of Advanced Colorectal CancerChia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 1
NCT07653685Not Yet Recruiting
Phase 1
A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizum...Chia Tai Tianqing Pharmac...
NCT07655440
Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)Stanford UniversityNot Yet RecruitingPhase 4
NCT07655440Not Yet Recruiting
Phase 4
Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in...Stanford University
NCT07652853
Allergenic Risk Assessment of Hemp SeedUniversity Hospital, AngersNot Yet RecruitingNot Applicable
NCT07652853Not Yet Recruiting
Not Applicable
Allergenic Risk Assessment of Hemp SeedUniversity Hospital, Ange...
NCT07653399
Neurodevelopmental Treatment for Balance and Mobility in Children With Down SyndromeIstanbul Nisantasi UniversityCompletedNot Applicable
NCT07653399Completed
Not Applicable
Neurodevelopmental Treatment for Balance and Mobility in Children With Down Synd...Istanbul Nisantasi Univer...
NCT07653269
Predicting Risk of Progression of Early to Late AMD in the Aging Eye Through Imaging and Multimodal EvaluationSingapore Health ServicesRecruiting
NCT07653269Recruiting
—
Predicting Risk of Progression of Early to Late AMD in the Aging Eye Through Ima...Singapore Health Services
NCT07654647
Clinical Evaluation of Patient-Specific 3D-Printed Titanium Implants for Facial Reconstruction.Tishreen UniversityRecruitingNot Applicable
NCT07654647Recruiting
Not Applicable
Clinical Evaluation of Patient-Specific 3D-Printed Titanium Implants for Facial...Tishreen University
NCT07653126
A Study of Peptide Receptor Radionuclide Therapy (PRRT) Use in Neuroendocrine Tumor (NET) Patients in GermanyNovartis PharmaceuticalsCompleted
NCT07653126Completed
—
A Study of Peptide Receptor Radionuclide Therapy (PRRT) Use in Neuroendocrine Tu...Novartis Pharmaceuticals
Result Breakdown
Not yet recruiting9 (45%)
Recruiting8 (40%)
Completed2 (10%)
Enrolling by invitation1 (5%)
not_applicable9 (45%)
Not Specified4 (20%)
Phase 33 (15%)
Phase 42 (10%)
Phase 21 (5%)
Phase 11 (5%)